Skip to main content

Advertisement

Log in

Standardized treatment of chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the efficacy and the influence on quality of life (QOL) of syndrome differentiation treatment with Chinese medicine (CM) for opioid-induced constipation as well as the safety and influence on analgesic effect of opioids.

Methods

Totally 406 cases enrolled from 53 collaborating medical centers were randomly assigned to a CM group and a control group. The CM group were treated with CM decoction based on syndrome differentiation, and the control group were treated with Phenolphthalein Tablet. Both groups were treated for 14 days. Cleveland constipation score (CCS), numerical rating scale (NRS) of pain and Chinese version of European Organisation for Research and Treatment of Cancer, Quality of Life Questionnaire-C30 V3.0 (EORTC QLQ-C30 V3.0) were used to evaluate the efficacy, pain controlled and QOL status.

Results

The comparisons of CCS score reduction and QOL between the two groups after treatment suggested that the improvements of constipation and QOL in the CM group were better than that in the control group (P<0.05). The total efficiency of the CM group was better than the control group (93.5% vs. 86.4%, P<0.05). There was no significant difference in NRS scores between before and after treatment in both groups. There was no serious drug-related adverse event during the course of study.

Conclusion

CM decoction could effectively treat opioid-induced constipation and improve patients’ QOL at the same time. It is safe and doesn’t affect the analgesic effect of opioids when treating constipation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Refrences

  1. Cohen MZ, Easley MK, Ellis C, Hughes B, Ownby K, Rashad BG, et al. Cancer pain management and the JCAHO’s pain standards:an institutional challenge. J Pain Symptomf Manage 2003;25:519–527.

    Article  Google Scholar 

  2. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB. The epidemiology of cancer pain. Cancer Investigat 2005;23:182–190.

    Article  Google Scholar 

  3. Svendsen KB, Andersen S, Arnason S, Arnér S, Breivik H, Heiskanen T, et al. Breakthrough pain in malignant and nonmalignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005;9:195–206.

    Article  PubMed  Google Scholar 

  4. World Health Organization. Cancer pain relief. 2nd ed. Geneva, Switzerland: World Health Organization;1996.

    Google Scholar 

  5. Sun Y, Shi YK. Manual of clinical oncology. Beijing: People’s Medical Publishing House; 2007:277.

    Google Scholar 

  6. Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542–2554.

    CAS  PubMed  Google Scholar 

  7. Yu CP, An JX. How to prevent and control opioid-induced constipation. China Prescript Drug (Chin) 2008;8:74–76.

    Google Scholar 

  8. Liu M, Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia. J Pain Symptom Manage 2002;23:48–53.

    Article  PubMed  Google Scholar 

  9. Wang LN, Li J, Li DR, Lin HS. The status quo of the treatment of opioid-induced constipation with Chinese medicine. Chin J Integr Tradit West Med (Chin) 2010;16:116–119.

    CAS  Google Scholar 

  10. American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol 2005;100(Suppl 1):S1–S4.

    Article  Google Scholar 

  11. Ministry of Health of the People’s Republic of China. Guideline for Clinical Study of New Chinese Medicines. Beijing, China: Ministry of Health of the People’s Republic of China; 1993:131–133.

    Google Scholar 

  12. EORTC Quality of Life Group. Guidelines for assessing quality of life in EORTC clinical trials. Brussels, Belgium: Quality Life Unit, EORTC Data Center 2002;22(15):21–24.

    Google Scholar 

  13. Wa CH, Chen MQ, Zhang CZ, Tang XL, Meng Q, Zhang XQ. The Chinese version of EORTC QLQ-C3 form in evaluation of QOL for patients with cancer. J Pract Oncol (Chin) 2005;10:353–355.

    Google Scholar 

  14. Swarm R, Abernethy AP, Anghelescu DL, Benedetti C, Blinderman CD, Boston B, et al. NCCN clinical practice guidelines in oncology on adult cancer pain. J Natl Compr Canc Netw 2010;8:1055.

    Google Scholar 

  15. Common Terminology Criteria for Adverse Events v3.0. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed July 30, 2011.

  16. Wood JD, Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004;16:17–28.

    Article  PubMed  Google Scholar 

  17. Galligan JJ, Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005;17:643–653.

    Article  CAS  PubMed  Google Scholar 

  18. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil 2004;16:383–394.

    Article  PubMed  Google Scholar 

  19. Choi YS, Billings JA. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002;24:71–90.

    Article  CAS  PubMed  Google Scholar 

  20. Gu Y J, Chen J, Sun YY, Zhang X. Clinical observation on Jiangni Kuanchang Decoction for opioid-related constipation. Liaoning J Tradit Chin Med (Chin) 2009;36:233–234.

    Google Scholar 

  21. Tian DL. Internal medicine of traditional Chinese medicine. Beijing: People’s Medical Publishing House; 2006:226–230.

    Google Scholar 

  22. Zhao YL, Zhang ZH, Wang ZR. Relationship between purgative effect of Rhubarb and 5-HT and it’s receptor in duodenum tissues. J Yunnan Univ Tradit Chin Med (Chin) 2002;25:1–3.

    Google Scholar 

  23. Yu M, Luo YL, Zheng JW, Ding YH, Li W, Zheng TZ, et al. Effects of Rhubarb on isolated gastric muscle strips of guinea pigs. World J Gastroenterol 2005;11:2670–2673.

    PubMed  Google Scholar 

  24. Zhang QR, Li L, Chen DS, Peng JX, Wang XW. Effects of Cortex magnoliae officinalis, Fructus aurantii immaturus, Rhubarb and Pericarpium citri reticulatae on rabbits’ isolated fundal smooth muscle movement. Chin J Tradit Med Sci Technol (Chin) 2008;15:279–280.

    Google Scholar 

  25. Wang, CF, Yang DZ, Wei YQ, Xun QY. Study on the effect of Fructus aurantii immaturus on myoelectric of gastrointestinal tract in rats. J Southeast Univ (Med Sci Ed, Chin) 2001;20:153–154.

    Google Scholar 

  26. Zhang QR, Ding L, Zhao XM, Guo XD, Li L. The effect of Cortex magnoliae officinalis on the movement of rabbits’ dissociated smooth muscles of intestine and stomach. Shaanxi Med J (Chin) 2007;36:656–659.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li-zhu Lin  (林丽珠).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Cm., Lin, Lz. & Zhang, Ex. Standardized treatment of chinese medicine decoction for cancer pain patients with opioid-induced constipation: A multi-center prospective randomized controlled study. Chin. J. Integr. Med. 20, 496–502 (2014). https://doi.org/10.1007/s11655-014-1864-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-1864-9

Keywords

Navigation